Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-22

Clinical Trial Update: FIH XON7 in Advanced/Metastatic Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update announces a first-in-human study of XON7 in patients with advanced solid tumor and metastatic cancer, with Phase 1 and Phase 2 curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • XON7

Snippet

Sponsor: Xenothera SAS | Conditions: Advanced Solid Tumor, Metastatic Cancer | Phase 1, Phase 2 | Status: RECRUITING